Last reviewed · How we verify

NCT04203810

Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)

Completed NA Last updated 28 July 2022
What this trial tests

NA trial testing Ectoin® Mouth and Throat Spray Althaea Honey (ERS09) in Sore Throat in 194 participants. Completed in 4 December 2020.

Timeline
14 January 2020
Primary endpoint
4 December 2020
4 December 2020

Quick facts

Lead sponsorBitop AG
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment194
Start date14 January 2020
Primary completion4 December 2020
Estimated completion4 December 2020
Sites12 locations across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Bitop AG — full company profile →

Who can join

12 and older, any sex, with Sore Throat or Acute Pharyngitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this multicentre, actively controlled, randomized, open label, parallel group, prospective, comparator study is to collect data on the clinical effectiveness and tolerability of the medical device ERS09 compared to a well-established comparator spray in the symptomatic treatment of sore throat due to acute pharyngitis and dry cough.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effectiveness and Tolerability of Ectoin<sup>®</sup> Mouth and Throat Spray Althaea Honey (ERS09) for Sore Throat due to Acute Pharyngitis and Dry Cough: A Multicentre, Actively Controlled, Open Label Study in Germany.
    Roventa DLC, Pieper-Fürst U, Acikel C, Santos D, et al · · 2023 · cited 2× · PMID 37762768 · DOI 10.3390/jcm12185813
  2. Abstracts, 16. Deutscher Allergiekongress, Dresden, 30. September-2. Oktober 2021
    · 2021 · cited 1×
  3. Abstracts of the 16th German Allergy Congress Dresden, September 30–October 2, 2021
    · 2021

Verify or expand the search:

Other recruiting trials for Sore Throat

Currently open trials in the same condition.

Other Bitop AG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04203810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing